Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.76%
#4 aPriori aPriori +108.27%
#5 Bedrock Bedrock +74.39%
#6 Cysic Cysic +49.09%
#7 Prom Prom +38.71%
#8 Playnance Playnance +35.10%
#9 COTI COTI +26.15%
#10 Nillion Nillion +24.13%
Coin of the day
Wrapped One Wrapped One
Настройки
Язык
Pусский
Валюта
USD
Тема
Fresh2 Group Limited Fresh2 Group Limited

Fresh2 Group Limited

FRES
Ранг среди акций #42683
Fresh2 Group Limited, a biotechnology company established in New York, New... Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.
Цена акции
$0.85
Последняя синхронизация: 2025-01-21
Рыночная капитализация
$411.40
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Fresh2 Group Limited (FRES)

Категория

Healthcare
Выручка компании Fresh2 Group Limited (FRES)
Выручка на Jun 2023 TTM: $1.64M
Согласно последним финансовым отчетам Fresh2 Group Limited, текущая выручка компании (TTM) составляет $1.64M. В 2021 году компания получила выручку $2.79M меньше, чем выручке в 2020 году, которая составила $2.97M. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Fresh2 Group Limited с 2017 по 2026
Выручка на конец каждого года
Год Выручка Изменить
2026 (TTM) $1.64M -5.98%
2022 $1.75M -37.49%
2021 $2.79M -5.89%
2020 $2.97M 91.09%
2019 $1.55M 0.32%
2018 $1.55M 81.73%
2017 $851.95K 0.00%
Выручка аналогичных компаний или конкурентов
Компания Выручка Разница в выручке Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 768,932.17%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 366,697.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 615,816.94%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR